A new trading day began on Monday, with Akebia Therapeutics Inc. (NASDAQ: AKBA) stock price up 2.52% from the previous day of trading, before settling in for the closing price of $1.59. AKBA’s price has ranged from $0.78 to $2.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 5.16%. Meanwhile, its annual earnings per share averaged 13.10%. With a float of $199.72 million, this company’s outstanding shares have now reached $210.29 million.
The extent of productivity of a business whose workforce counts for 167 workers is very important to gauge. In terms of profitability, gross margin is 61.9%, operating margin of -20.21%, and the pretax margin is -23.18%.
Akebia Therapeutics Inc. (AKBA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Akebia Therapeutics Inc. is 5.03%, while institutional ownership is 24.10%. The most recent insider transaction that took place on May 13 ’24, was worth 15,140. In this transaction SVP, Chief Legal Officer of this company sold 12,016 shares at a rate of $1.26, taking the stock ownership to the 651,243 shares. Before that another transaction happened on May 13 ’24, when Company’s SVP, Chief Operating Officer sold 34,840 for $1.26, making the entire transaction worth $43,898. This insider now owns 672,092 shares in total.
Akebia Therapeutics Inc. (AKBA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 13.10% per share during the next fiscal year.
Akebia Therapeutics Inc. (NASDAQ: AKBA) Trading Performance Indicators
Here are Akebia Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.26 in one year’s time.
Technical Analysis of Akebia Therapeutics Inc. (AKBA)
The latest stats from [Akebia Therapeutics Inc., AKBA] show that its last 5-days average volume of 3.04 million was inferior to 3.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 76.92%. Additionally, its Average True Range was 0.08.
During the past 100 days, Akebia Therapeutics Inc.’s (AKBA) raw stochastic average was set at 93.26%, which indicates a significant increase from 86.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.14% in the past 14 days, which was higher than the 71.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4101, while its 200-day Moving Average is $1.3837. Now, the first resistance to watch is $1.6647. This is followed by the second major resistance level at $1.6993. The third major resistance level sits at $1.7392. If the price goes on to break the first support level at $1.5902, it is likely to go to the next support level at $1.5503. The third support level lies at $1.5157 if the price breaches the second support level.
Akebia Therapeutics Inc. (NASDAQ: AKBA) Key Stats
With a market capitalization of 342.77 million, the company has a total of 209,596K Shares Outstanding. Currently, annual sales are 194,620 K while annual income is -51,930 K. The company’s previous quarter sales were 43,650 K while its latest quarter income was -8,580 K.
